Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy in patients with very high-risk prostate cancer Patients. 2021

Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
Department of Urology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.

Patients with very-high-risk prostate cancer (VHRPCa) have earlier biochemical recurrences (BCRs) and higher mortality rates. It remains unknown whether extended robot-assisted laparoscopic prostatectomy (eRALP) without neoadjuvant or adjuvant therapy can improve the outcomes of VHRPCa patients. We aimed to determine the feasibility and efficacy of eRALP as a form of monotherapy for VHRPCa. Data from 76 men who were treated with eRALP without neoadjuvant/adjuvant therapy were analyzed. eRALP was performed using an extrafascial approach. Extended pelvic lymph node (LN) dissection (ePLND) included nodes above the external iliac axis, in the obturator fossa, and around the internal iliac artery up to the ureter. The outcome measures were BCR, treatment failure (defined as when the prostate-specific antigen level did not decrease to <0.1 ng/ml postoperatively), and urinary continence (UC). Kaplan-Meier, logistic regression, and Cox proportional-hazards model were used to analyze the data. The median operative time was 246 min, and median blood loss was 50 ml. Twenty-one patients experienced postoperative complications. Median follow-up was 25.2 months; 19.7% of patients had treatment failure. Three-year, BCR-free survival rate was 62.0%. Castration-resistant prostate cancer-free survival rate was 86.1%. Overall survival was 100%. In 55 patients who had complete postoperative UC data, 47 patients (85.5%) recovered from their UC within 12 months. Clinical stage cT3b was an independent preoperative treatment failure predictor (p = 0.035), and node positivity was an independent BCR predictor (p = 0.037). The small sample size and retrospective nature limited the study. This approach was safe and produced acceptable UC-recovery rates. Preoperative seminal vesicle invasion is associated with treatment failure, and pathological LN metastases are associated with BCR. Therefore, our results may help informed decisions about neoadjuvant or adjuvant therapies in VHRPCa cases. Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection without adjuvant therapy is safe and effective for some patients with very-high-risk prostate cancer. The clinical stage and node positivity status predicted monotherapy failure, which may indicate good adjuvant therapy candidate.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008297 Male Males
D010388 Pelvis The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM. Pelvic Region,Region, Pelvic
D010535 Laparoscopy A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy. Celioscopy,Laparoscopic Surgical Procedures,Peritoneoscopy,Surgical Procedures, Laparoscopic,Laparoscopic Assisted Surgery,Laparoscopic Surgery,Laparoscopic Surgical Procedure,Procedure, Laparoscopic Surgical,Procedures, Laparoscopic Surgical,Surgery, Laparoscopic,Surgical Procedure, Laparoscopic,Celioscopies,Laparoscopic Assisted Surgeries,Laparoscopic Surgeries,Laparoscopies,Peritoneoscopies,Surgeries, Laparoscopic,Surgeries, Laparoscopic Assisted,Surgery, Laparoscopic Assisted
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
February 2017, European urology,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
January 2024, BMC urology,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
October 2006, Urology,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
October 2012, Journal of laparoendoscopic & advanced surgical techniques. Part A,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
March 2023, Scientific reports,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
January 2018, Journal of endourology case reports,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
April 2019, Archivos espanoles de urologia,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
April 2022, Journal of laparoendoscopic & advanced surgical techniques. Part A,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
December 2017, Clinical genitourinary cancer,
Noriyoshi Miura, and Naoya Sugihara, and Keisuke Funaki, and Toshio Kakuda, and Kanae Koyama, and Ryuta Watanabe, and Yuichiro Sawada, and Terutaka Noda, and Kenichi Nishimura, and Tetsuya Fukumoto, and Yuki Miyauchi, and Tadahiko Kikugawa, and Takashi Saika
April 2022, International journal of clinical oncology,
Copied contents to your clipboard!